文献速递主动脉疾病

血管外科医生对血管遗传学检测的实践模式与障碍调查

Practice Patterns and Barriers to Vascular Genetic Testing Among Vascular Surgeons.
PubMed 文献 · Ann Vasc Surg · 2024-04-08

通过社交媒体对15个国家171名血管外科医生进行匿名问卷调查,了解其血管遗传学检测的实践模式、动机与障碍。大多数受访者有兴趣将基因检测纳入实践,但非学术机构医生在保险覆盖、检测成本和遗传咨询可及性方面面临更大障碍。基于证据的专业学会指南是促进检测整合的最强动机因素。

要点

  • 86%的血管外科医生有兴趣将基因检测纳入实践,态度并非主要障碍。
  • 学术机构医生比医院和私立机构医生更常诊治已知遗传性主动脉病患者、转诊遗传学家及获得遗传咨询资源。
  • 非学术机构医生认为检测障碍更显著,主要障碍为保险覆盖、检测成本和遗传咨询可及性。

核心结论

  • 血管外科医生对将基因检测纳入主动脉病患者的实践持积极态度,但实际实施面临检测和咨询方面的障碍,尤其在非学术机构中。
  • 未来应聚焦于基于证据的学会指南、继续医学教育以促进采纳,并促进遗传咨询的可及性。

研究设计与样本

  • 匿名27问题调查于2022年11月至12月通过社交媒体平台分发,分析包括汇总统计和非配对t检验,比较对纳入检测的兴趣和实践类型的应答。

主要发现

  • 共171名来自15个国家的血管外科医生回应(23%为受训者),59%在培训期间接受过血管遗传学教育,86%有兴趣将基因检测纳入实践。
  • 学术机构医生比医院和私立机构医生更可能在过去一年内诊治已知遗传性主动脉病患者(83% vs. 56% vs. 27%;P < 0.01)。
  • 学术机构医生比医院和私立机构医生更可能曾转诊至医学遗传学家(78% vs. 51% vs. 9%;P < 0.01)。
  • 学术机构医生比医院和私立机构医生更可能获得遗传咨询师或遗传学家的资源(66% vs. 46% vs. 0%;P < 0.01)。
  • 非学术机构医生认为检测障碍更显著,主要障碍为保险覆盖、检测成本和遗传咨询可及性。

关键数值与推荐

  • 基于证据的专业学会指南被受访者评为促进检测整合的最强动机因素。
  • 障碍评分在非学术机构医生中更高,具体数值原文未报告。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Engaging patients living with or at risk of aortic dissection via the Aortic Dissection Collaborative, physician education in vascular genetics was identified as a research priority. We surveyed vascular surgeons to characterize practice patterns, motivations, and barriers regarding aortopathy genetic testing. METHODS: An anonymous 27-question survey was distributed on social media platforms between November and December 2022. Domains included demographics, vascular genetic education, testing attitudes and utilization, and experience in treating patients with genetic vascular aortopathies. The analysis included summary statistics and unpaired t-test to compare responses by interest in incorporating testing and practice type. RESULTS: A total of 171 vascular surgeons from 15 countries responded to the survey (23% trainees). Over half received vascular genetics education during training (59%), and most (86%) were interested in incorporating genetic testing into their practice. Academic surgeons were more likely to have cared for a patient with a known genetic aortopathy over the past year than surgeons in hospital-based and private practices (83% vs. 56% vs. 27%; P < 0.01), to have ever made a referral to a medical geneticist (78% vs. 51% vs. 9%; P < 0.01), and have access to genetic counselors or geneticists (66% vs. 46% vs. 0%; P < 0.01). Barriers to genetic testing were rated as more significant by surgeons in nonacademic practices, with top barriers being insurance coverage of testing, cost of genetic testing, and access to genetic counselors. Evidence-based professional society guidelines were the strongest rated motivating factor for testing incorporation among respondents. CONCLUSIONS: Vascular surgeon attitudes are not major barriers to incorporating genetic testing for patients with aortopathies; however, practical challenges regarding genetic testing and counseling are barriers to implementation especially for vascular surgeons in nonacademic practices. Future efforts should focus on evidence-based society guidelines, continuing medical education to increase adoption, and facilitating access to genetic counseling.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Dittman JM, Prakash SK, Gupta PC, et al. Practice Patterns and Barriers to Vascular Genetic Testing Among Vascular Surgeons. Ann Vasc Surg. 2024. PMID: 38599485. doi:10.1016/j.avsg.2024.01.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。